TRESIBA 100 IU

Tresiba 1OOU/ml Flextouch 3 ml belongs to a group of medication called ‘anti-diabetic’ primarily used
for the treatment of type I and type 2 diabetes mellitus in both children (above 1 year of age) and
adults. Diabetes is a disease where your body does not produce enough insulin to control the level of
your blood sugar. Treatment with Tresiba IOOU/ml Flextouch 3 ml helps to prevent complications from your diabetes.

Tresiba 1OOU/ml Flextouch 3 ml contains insulin degludec which is a fast-acting insulin that works
rapidly to normalize blood sugar levels by helping the sugar move from the blood into other tissues of
the body. It typically begins working after 60 minutes and is a long-acting insulin preparation (lasts for
more than 24 hours). It prevents the risk of having severe complications of diabetes. It stimulates the
recovery of sugar in muscle and fat cells and thus suppresses the production of sugar in the liver.

In patients with type 1 diabetes, Tresiba IOOU/ml Flextouch 3 ml must be used with another type of
insulin (like with short-acting insulin). On the other hand, in patients with type 2 diabetes, Tresiba
IOOU/ml Flextouch 3 ml can be used with another type of insulin or with oral antidiabetic medicines.

The common side effects of Tresiba IOOU/ml Flextouch 3 ml are hypokalaemia (low potassium),
hypoglycemia (low blood sugar level), local injection site reactions, lipodystrophy (fat deposition under the skin), rash, and pruritus (itch skin) which may occur at the injection site. Most of these side effects of Tresiba 1OOU/ml Flextouch 3 ml do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.